1. Dapagliflozin improves Myocardial Flow Reserve in patients with Type 2 Diabetes: the DAPAHEART Trial. (3rd October 2022) Authors: D'Amario, D; Leccisotti, L; Cinti, F; Sorice, G P; Lorusso, M; Guzzardi, M A; Mezza, T; Cocchi, C; Capece, U; Indovina, L; Ferraro, P M; Iozzo, P; Giordano, A; Giaccari, A; Crea, F Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P256 Urinary lithogenic profile and gut and urinary microbiota in patients with inflammatory bowel diseases. (30th January 2023) Authors: Mignini, I; Masucci, L; De Maio, F; Laterza, L; Scaldaferri, F; Settanni, C R; Napolitano, D; Baroni, S; Garcovich, M; Riccardi, L; Gasbarrini, A; Ferraro, P M; Papa, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗